Picard Medical (PMI) Convertible Debt (2024 - 2025)

Picard Medical posted quarterly Convertible Debt of $14.8 million for Q2 2025, down 0.51% on a QoQ basis from $14.8 million in Q4 2024.

Picard Medical (PMI) has 2 years of Convertible Debt data on file, last reported at $14.8 million in Q2 2025.

  • For the quarter ending Q2 2025, Convertible Debt changed N/A year-over-year to $14.8 million; the trailing twelve-month figure through Jun 2025 stood at $14.8 million (changed N/A YoY), and the FY2024 full-year result was $14.8 million, changed N/A from the prior year.
  • Convertible Debt for Q2 2025 stood at $14.8 million, down from $14.8 million in the prior quarter.
  • Across five years, Convertible Debt topped out at $14.8 million in Q4 2024 and bottomed at $14.8 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Picard Medical 12.10 Mn 12.10 Mn 275,000.00

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 14.75 Mn
Dec 31, 2024 14.83 Mn